Yiying Zeng

5PUBLICATIONS
9CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Central nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 28, 2026
Study on Synergistic Treatment of Pancreatic Cancer by Multiple Small Interfering Ribonucleic Acid Lipid Nanoparticles of Disk Domain Receptor 1, Transforming Growth Factor β1, Tumor-Associated Calcium Signal Transduction Protein 2, and Polyligand Proteoglycan 1.

|Jan 23, 2024
The Efficacy and Safety of Polyethylene Glycol Cholesterol- and Tocopherol Polyethylene Glycol 1000 Succinate-Modified Transforming Growth Factor β1 Small Interfering RNA Lipid Nanoparticles in the Treatment of Paclitaxel-Resistant Non-Small-Cell Lung Cancer.

Zhaowu Zeng, Xianglong Zeng, Xinyi Li

|Oct 13, 2021
Recent Advances in Understanding the Mechanisms of Elemene in Reversing Drug Resistance in Tumor Cells: A Review.

Tiantian Tan, Jie Li, Ruhua Luo

|May 06, 2020
Nanoparticle Drug Delivery System for Glioma and Its Efficacy Improvement Strategies: A Comprehensive Review.

Jie Li, Jiaqian Zhao, Tiantian Tan

|May 05, 2019
The Preparation, Determination of a Flexible Complex Liposome Co-Loaded with Cabazitaxel and β-Elemene, and Animal Pharmacodynamics on Paclitaxel-Resistant Lung Adenocarcinoma.

Yi-Ying Zeng, Yi-Jun Zeng, Na-Na Zhang

Pageof 1

Frequent Collaborators

4 joint publications

Zhaowu Zeng

2 joint publications

Tian Xie

1 joint publications

Tiantian Tan

1 joint publications

Jie Li